Google
Trusted Resources: News & Events
Latest announcements and gatherings
A multiple drug approach to preventing sickle cell crisis
Sickle cell disease is characterized by recurrent episodes of “sickle crisis,” also known as vaso-occlusive crisis, in which a patient’s red blood cells change shape, clump together and block the flow of blood in small vessels resulting in pain and organ damage.
In an editorial in the current issue of the New England Journal of Medicine, a Boston University School of Medicine (BUSM) researcher stresses the need for a multi-pronged approach to treating sickle-cell disease in order to prevent these harmful episodes.
+myBinderRelated Content
-
Beliefs about hydroxyurea in youth with sickle cell diseaseBackground: Hydroxyurea reduces complic...
-
Endocrine and Metabolic Complications in Children and Adolescents With Sickle Cell Disease: An Italian Cohort StudyBackground: Children with Sickle Cell D...
-
Long-term opioids may not be best pain management option for all sickle cell patientsSmall study shows some on opioids report...
-
MARAC Advisory Statement: Gene Therapy & Bone Marrow TherapiesPlease note: A previous version of this ...
-
Patients With Sickle Cell Disease may Have Lower Risk for C. DifficileFindings from a retrospective cohort stu...
-
CTX001 Continues to Show Promise in Severe SCDA single dose of CTX001, an experimental...
-
Bioverativ and Bicycle Therapeutics Enter into Strategic Research Collaboration to Develop Therapies for Hemophilia ...Bioverativ Inc. (NASDAQ: BIVV), a global...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.